BioHealth News Archive
Living like a leader: A day with Children’s National Health System CEO Dr. Kurt Newman
Between clinical objectives, financial concerns, patient needs and complex payer dynamics, there seem to be too few hours in the day for healthcare executives…
Read More
GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia – Business Wire
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today dosing of the first patient in the company’s Phase 3 clinical trial of uproleselan (GMI-1271) in relapsed/refractory AML.…
Read More
Emergent Bio’s Zika vaccine shows positive action in early-stage study – Seeking Alpha
Results from a Phase 1 clinical trial evaluating the safety and immunogenicity of Emergent BioSolutions' (NYSE:EBS) Zika vaccine, VLA1601, showed a favorable safety profile…
Read More
IBBR investigator to lead $3.9M NIH-funded project to develop next generation HIV-1 immunotherapy agents
IBBR researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to…
Read More
Paragon Bioservices Named to Deloitte’s Technology Fast 500™
Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines,…
Read More
What health IT needs to look like in 2019 to be successful – MedCity News
There’s no doubt that now is an exciting time for health IT. Many forward-thinking software companies are applying predictive models to create solutions that…
Read More
D.C.’s original site competition – The Washington Post
Amazon announced its HQ2 decision last Tuesday, splitting the decision between Crystal City and New York. But an earlier competition to site the nation’s…
Read More
Arena Inks $1.2 Billion Deal With United Therapeutics – Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) | Seeking Alpha
Arena Pharmaceuticals (ARNA) and United Therapeutics (UTHR) announced on Nov. 15 that the two companies have reached a deal on the pulmonary arterial hypertension…
Read More
Baltimore-based AsclepiX Therapeutics raises $5M – Technical.ly Baltimore
Johns Hopkins spinout AsclepiX Therapeutics raised $5 million in new funding that will assist in development of new treatment for eye diseases that are…
Read More
2019 California Life Sciences Industry Report – California Life Sciences Association
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, and PwC US, are proud to release the 2019 California Life…
Read More
5 Telehealth Insights from CMS’ Seema Verma – HealthLeaders Media
Telehealth is changing the face of healthcare, and Medicare must adapt, said the CMS administrator. Innovation is vital to the evolution and sustainability of…
Read More
TEDx Amplifies UMB’s Cutting-Edge Innovations – University of Maryland, Baltimore
The audience seated in an intimate ballroom at the University of Maryland, Baltimore (UMB) on Nov. 9 turned its attention to a small stage…
Read More
Opportunities in genomic testing and precision medicine – McKinsey
Advanced analysis of genomic data integrated with electronic medical records and other data sets, combined with effective reimbursement strategies and full data-regulatory compliance, will…
Read More
HISTORIC DAY: Virginia Tech Innovation Campus key to Virginia attracting Amazon HQ2 – Virginia Tech
Virginia emerged as a winner in the fierce, nationwide competition to house a headquarters for Amazon. The commonwealth stepped up with a standout higher…
Read More
Rexahn Pharmaceuticals Announces Leadership Transition – Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve outcomes in cancers that are difficult to treat,…
Read More